VRG Therapeutics Overview
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.07M
- Investors
-
6
VRG Therapeutics General Information
Description
Developer of a mini-protein technology designed to bring new treatments for poorly managed diseases. The company's technology optimizes peptides of natural origin to create cellular and gene therapy products that treat central nervous system diseases, enabling medical professionals to tackle diseases through mechanisms that conventional biopharmaceutical approaches cannot achieve.
Contact Information
Website
www.vrgtherapeutics.comCorporate Office
- BioPartner 3, J.H. Oortweg 21
- 2333 CH Leiden
- Netherlands
Corporate Office
- BioPartner 3, J.H. Oortweg 21
- 2333 CH Leiden
- Netherlands
VRG Therapeutics Timeline
VRG Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jul-2025 | $2.07M | Completed | Pre-Clinical Trials | ||
| 7. Later Stage VC | Completed | Startup | ||||
| 6. Grant | 01-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 5. Later Stage VC (Series A) | 14-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | Completed | Pre-Clinical Trials | ||||
| 3. Grant | 22-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 12-Dec-2019 | $1.07M | Completed | Pre-Clinical Trials | ||
| 1. Grant | 15-Nov-2017 | $1.87M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VRG Therapeutics Patents
VRG Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024502586-A | Chlorotoxin derivatives and their uses | Active | 30-Dec-2020 | ||
| CA-3203901-A1 | Chlorotoxin derivatives and use thereof | Active | 30-Dec-2020 |
VRG Therapeutics Signals
VRG Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Research, Development and Innovation Office | Government | |||
| Széchenyi Funds | Venture Capital | Minority | ||
| Vascular Venture | Venture Capital | Minority | ||
| National Office for Research, Development and Innovation | Corporation | |||
| Lief Holdings | Corporation | Minority |
VRG Therapeutics FAQs
-
Where is VRG Therapeutics headquartered?
VRG Therapeutics is headquartered in Leiden, Netherlands.
-
What is the size of VRG Therapeutics?
VRG Therapeutics has 24 total employees.
-
What industry is VRG Therapeutics in?
VRG Therapeutics’s primary industry is Biotechnology.
-
Is VRG Therapeutics a private or public company?
VRG Therapeutics is a Private company.
-
What is VRG Therapeutics’s current revenue?
The current revenue for VRG Therapeutics is .
-
How much funding has VRG Therapeutics raised over time?
VRG Therapeutics has raised $11.1M.
-
Who are VRG Therapeutics’s investors?
National Research, Development and Innovation Office, Széchenyi Funds, Vascular Venture, National Office for Research, Development and Innovation, and Lief Holdings are 5 of 6 investors who have invested in VRG Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process